Phase 2 Study of LUM-201 in Children With Growth Hormone Deficiency (OraGrowtH210 Trial) (OraGrowtH210)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04614337 |
Recruitment Status :
Active, not recruiting
First Posted : November 4, 2020
Last Update Posted : February 20, 2024
|
Sponsor:
Lumos Pharma
Information provided by (Responsible Party):
Lumos Pharma
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Active, not recruiting |
---|---|
Estimated Primary Completion Date : | October 2024 |
Estimated Study Completion Date : | October 2024 |